Pedometer Coaching to Promote Postoperative Ambulation

NCT06259591 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2024-02-14

No results posted yet for this study

Summary

The goal of this randomized controlled trial is to evaluate whether remote pedometer follow-up and virtual coaching can improve ambulation after major abdominopelvic surgery, and how this affects key postoperative outcomes.

The main questions it aims to answer are:

* Does pedometer-guided ambulation coaching increases ambulation after surgery?
* Does pedometer-guided coaching improve satisfaction, quality of recovery, while reducing postoperative complications?

Participants will be asked to install a pedometer app for the purpose of data sharing. Study personnel will compare pedometer follow-up plus text message coaching (intervention) with pedometer follow-up only (control) to investigate whether coaching improves adherence to the postoperative ambulation recommendation, and whether this leads to improvement of the secondary outcomes.

Conditions

  • Postoperative Outcomes

Interventions

BEHAVIORAL

Pedometer follow-up

The daily step count will be obtained from the patients using a pedometer app (OutWalk) from day 8 to day 30 after surgery.

BEHAVIORAL

Ambulation coaching

Patients will receive coaching text messages every Monday, Wednesday and Friday between day 8 and day 30 after surgery, based on a pre-fixed template.

Sponsors & Collaborators

Principal Investigators

  • Sergio D Bergese, MD, FASA · Stony Brook Medicine

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-31
Primary Completion
2024-06-30
Completion
2024-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06259591 on ClinicalTrials.gov